Von Willebrand disease type 2A (Q100601): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
A doença de von Willebrand tipo 2A (DVW tipo 2A) é um subtipo de DVW tipo 2 caracterizada por um transtorno hemorrágico associado a uma redução da afinidade do fator de von Willebrand (FVW) pelas plaquetas e pelo subendotélio, causada por uma deficiência de multímeros de FVW de alto peso molecular. A doença manifesta-se anomalias do sangramento mucocutâneo (menorragia, epistaxe, hemorragia gastrointestinal, etc.). | |||
| description / en | description / en | ||
Type 2A von Willebrand disease (type 2A VWD) is a subtype of type 2 VWD characterised by a bleeding disorder associated with a decrease in the affinity of the Willebrand factor (von Willebrand factor; VWF) for platelets and the subendothelium caused by a deficiency of high molecular weight VWF multimers. The disease manifests as mucocutaneous bleeding anomalies (menorrhagia, epistaxis, gastrointestinal haemorrhage, etc.). | |||
Revision as of 17:19, 16 August 2026
Type 2A von Willebrand disease (type 2A VWD) is a subtype of type 2 VWD characterised by a bleeding disorder associated with a decrease in the affinity of the Willebrand factor (von Willebrand factor; VWF) for platelets and the subendothelium caused by a deficiency of high molecular weight VWF multimers. The disease manifests as mucocutaneous bleeding anomalies (menorrhagia, epistaxis, gastrointestinal haemorrhage, etc.).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_1009291548 |
||
| English | Von Willebrand disease type 2A |
Type 2A von Willebrand disease (type 2A VWD) is a subtype of type 2 VWD characterised by a bleeding disorder associated with a decrease in the affinity of the Willebrand factor (von Willebrand factor; VWF) for platelets and the subendothelium caused by a deficiency of high molecular weight VWF multimers. The disease manifests as mucocutaneous bleeding anomalies (menorrhagia, epistaxis, gastrointestinal haemorrhage, etc.). |
